← The Wire
TARANasdaq
Protara Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · CIK 1359931
Advancing transformative cell therapies and phospholipid substrate replacement therapies for cancer and rare diseases
red 8-K · 90d
$219M
Market cap
$4.16
Last close
+1.0%
1D
+1.2%
5D
989K
Volume
Price · last 39 sessions-23.7%
May 4L $3.65 · H $5.66Jun 29
244
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 29, 20268-KShareholder VoteJun 15, 2026424B5PROSPECTUS SUPPLEMENTMay 28, 202610-QQUARTERLY REPORTMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 28, 2026DEF 14APROXY STATEMENTApr 28, 20268-KReg FD DisclosureMar 30, 202610-KANNUAL REPORTMar 10, 20268-KResults of OperationsMar 10, 20268-KReg FD Disclosure · Company UpdateFeb 24, 20268-KCompany UpdateDec 15, 20258-KMaterial AgreementDec 8, 2025424B5PROSPECTUS SUPPLEMENTDec 5, 2025424B5PROSPECTUS SUPPLEMENTDec 4, 20258-KReg FD Disclosure · Company UpdateDec 3, 20258-KReg FD Disclosure · Company UpdateNov 19, 202510-QQUARTERLY REPORTNov 10, 20258-KResults of OperationsNov 10, 202510-QQUARTERLY REPORTAug 11, 20258-KResults of OperationsAug 11, 20258-KShareholder VoteJun 12, 202510-QQUARTERLY REPORTMay 8, 20258-KResults of OperationsMay 8, 20258-KReg FD Disclosure · Company UpdateApr 28, 2025DEFA14AADDITIONAL MATERIALSApr 25, 2025DEF 14APROXY STATEMENTApr 25, 202510-KANNUAL REPORTMar 5, 20258-KResults of OperationsMar 5, 20258-KReg FD Disclosure · Company UpdateJan 13, 2025SC 13GTHE SCHEDULE 13GDec 17, 20248-KMaterial Agreement · Reg FD DisclosureDec 11, 2024424B5PROSPECTUS SUPPLEMENTDec 11, 2024424B5PROSPECTUS SUPPLEMENTDec 9, 20248-KReg FD Disclosure · Company UpdateDec 5, 2024SC 13GSC 13GNov 18, 2024SC 13GPROTARA THERAPEUTICS, INC.Nov 14, 202410-QQUARTERLY REPORTNov 12, 20248-KResults of OperationsNov 12, 202410-QQUARTERLY REPORTAug 6, 20248-KResults of OperationsAug 6, 20248-KShareholder VoteJun 10, 202410-QQUARTERLY REPORTMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2024DEF 14APROXY STATEMENTApr 26, 2024SC 13GSC 13GApr 25, 2024SC 13GSC 13GApr 22, 2024SC 13GSC 13GApr 9, 20248-KMaterial Agreement · Equity IssuanceApr 5, 20248-KExecutive ChangeMar 18, 202410-KANNUAL REPORTMar 13, 20248-KResults of OperationsMar 13, 202410-QQUARTERLY REPORTNov 3, 20238-KResults of OperationsNov 3, 202310-QQUARTERLY REPORTAug 3, 20238-KResults of OperationsAug 3, 20238-KShareholder VoteJun 8, 202310-QQUARTERLY REPORTMay 4, 20238-KResults of OperationsMay 4, 20238-KReg FD DisclosureMay 2, 20238-KReg FD DisclosureApr 28, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2023DEF 14APROXY STATEMENTApr 26, 20238-KReg FD DisclosureMar 10, 202310-KANNUAL REPORTMar 8, 20238-KResults of OperationsMar 8, 20238-KExecutive Change · Reg FD DisclosureJan 30, 20238-KCompany UpdateJan 5, 202310-QQUARTERLY REPORTNov 3, 20228-KResults of OperationsNov 3, 202210-QQUARTERLY REPORTAug 9, 20228-KResults of OperationsAug 9, 20228-KExecutive ChangeJul 18, 20228-KExecutive Change · Reg FD DisclosureJun 21, 20228-KShareholder VoteJun 9, 202210-QQUARTERLY REPORTMay 5, 20228-KResults of OperationsMay 5, 2022DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 27, 2022DEF 14ADEFINITIVE PROXY STATEMENTApr 27, 2022
Similar companies
Comparable business profile · signals at a glance